Evidence map›Paper›PMID 34262915›Full record

ArticleFrontiers in medicine2021

The Scientific and Clinical Case for Reviewing Diagnostic Radiopharmaceutical Extravasation Long-Standing Assumptions.

Dustin Osborne, Ronald Lattanze, Josh Knowland, Tonia E Bryant, Iryna Barvi, Yitong Fu, Jackson W Kiser

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07174089 (New AI-based Technologies for Even Safer and More Precise Nuclear Medicine), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07174089 recruitingnot on this map

New AI-based Technologies for Even Safer and More Precise Nuclear Medicine

TypeobservationalSponsorAzienda USL Reggio Emilia - IRCCSRan2021 to 2026Enrolled1,500ConditionsPatients Undergoing PET/CT Investigation or Nuclear Medicine TherapyArmsRadEye SPRD-ER device: spectrometric radiation detector capable of detecting gamma radiation.
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Extravasation of Diagnostic Radiopharmaceuticals: A Wolf in Sheep's Clothing?Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Detection of Excess Presence ofFrontiers in medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Dustin OsborneRadiology Department, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.
Ronald LattanzeLucerno Dynamics LLC, Cary, NC, United States.
Josh KnowlandLucerno Dynamics LLC, Cary, NC, United States.
Tonia E BryantLucerno Dynamics LLC, Cary, NC, United States.
Iryna BarviLucerno Dynamics LLC, Cary, NC, United States.
Yitong FuRadiology Department, University of Tennessee Graduate School of Medicine, Knoxville, TN, United States.
Jackson W KiserDepartment of Molecular Imaging, Carilion Clinic, Roanoke, VA, United States.
Lucerno Dynamics (United States) · USUniversity of Tennessee at Knoxville · USCarilion Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse eventsdosimetryextravasationinfiltrationpatient harmquality

Identifiers

PMID34262915
PMCPMC8273265
OpenAlexW3174763386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.